Idera Pharmaceuticals to Host Conference Call and Webcast to Report Second Quarter 2014 Financial Results
August 05 2014 - 8:00AM
Business Wire
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage
biopharmaceutical company developing nucleic acid therapeutics for
patients with cancer and orphan diseases, today announced that the
Company will host a conference call and live audio webcast at 8:30
a.m. EDT on Tuesday, August 12, 2014 to report its second quarter
2014 financial results and provide a corporate update.
In order to participate in the conference call, please dial
1-800-901-5241 (domestic) or 1-617-786-2963 (international) and
provide the access code 28510971. The live webcast can be accessed
under “Investor Events” in the Investors section of the Company’s
website at www.iderapharma.com.
A replay of the call will be available at 1:30 p.m. EDT on
August 12, 2014 until 11:59 p.m. EDT on August 19, 2014. To access
the replay, please dial 1-888-286-8010 (domestic) or 1-617-801-6888
(international) and reference the access code 67213242. The
archived webcast will be available for 90 days in the Investors
section of Idera’s website at www.iderapharma.com.
About Idera Pharmaceuticals, Inc.Idera Pharmaceuticals is
a clinical-stage biopharmaceutical company developing a novel
therapeutic approach for the treatment of genetically defined forms
of B-cell lymphoma and orphan autoimmune diseases. Idera’s
proprietary technology involves creating novel nucleic acid
therapeutics designed to inhibit over-activation of Toll-like
Receptors (TLRs). In addition to its TLR programs, Idera is
developing gene silencing oligonucleotides (GSOs) that it has
created using its proprietary technology to inhibit the production
of disease-associated proteins by targeting RNA
Idera Pharmaceuticals, Inc.Lou Arcudi,
617-679-5517larcudi@iderapharma.com
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Apr 2023 to Apr 2024